AAAAAA
Results: 1-25/27
Authors:
Kareken, DA
Doty, RL
Moberg, PJ
Mosnik, D
Chen, SH
Farlow, MR
Hutchins, GD
Citation: Da. Kareken et al., Olfactory-evoked regional cerebral blood flow in Alzheimer's disease, NEUROPSYCHL, 15(1), 2001, pp. 18-29
Authors:
Lin, SZ
Zhang, YQ
Dodel, R
Farlow, MR
Paul, SM
Du, YS
Citation: Sz. Lin et al., Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons, NEUROSCI L, 315(1-2), 2001, pp. 61-64
Authors:
Farlow, MR
Citation: Mr. Farlow, Pharmacokinetic profiles of current therapies for Alzheimer's disease: Implications for switching to galantamine, CLIN THER, 23, 2001, pp. A13-A24
Authors:
Morris, JC
Farlow, MR
Ferris, SH
Kurz, AF
Maelicke, A
Rasmusen, L
Wilkinson, D
Yan, B
Citation: Jc. Morris et al., Panel discussion: Recommendations for prescribers, CLIN THER, 23, 2001, pp. A31-A39
Authors:
Takao, M
Ghetti, B
Murrell, JR
Unverzagt, FW
Giaccone, G
Tagliavini, F
Bugiani, O
Piccardo, P
Hulette, CM
Crain, BJ
Farlow, MR
Heyman, A
Citation: M. Takao et al., Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures, J NE EXP NE, 60(12), 2001, pp. 1137-1152
Authors:
Farlow, MR
Hake, A
Messina, J
Hartman, R
Veach, J
Anand, R
Citation: Mr. Farlow et al., Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression, ARCH NEUROL, 58(3), 2001, pp. 417-422
Authors:
Piccardo, P
Liepnieks, JJ
William, A
Dlouhy, SR
Farlow, MR
Young, K
Nochlin, D
Bird, TD
Nixon, RR
Ball, MJ
DeCarli, C
Bugiani, O
Tagliavini, F
Benson, MD
Ghetti, B
Citation: P. Piccardo et al., Prion proteins with different conformations accumulate in Geustmann-Straussler-Scheinker disease caused by A117V and F198S mutations, AM J PATH, 158(6), 2001, pp. 2201-2207
Authors:
Yazaki, M
Liepnieks, JJ
Murrell, JR
Takao, M
Guenther, B
Piccardo, P
Farlow, MR
Ghetti, B
Benson, MD
Citation: M. Yazaki et al., Biochemical characterization of a neuroserpin variant associated with hereditary dementia, AM J PATH, 158(1), 2001, pp. 227-233
Authors:
Farlow, MR
Murrell, JR
Unverzagt, FW
Phillips, M
Takao, M
Hulette, C
Ghetti, B
Citation: Mr. Farlow et al., Familial Alzheimer's disease with spastic paraparesis associated with a mutation at codon 261 of the presenilin 1 gene, ALZHEIMER'S DISEASE, 2001, pp. 53-60
Authors:
Lahiri, DK
Ge, YW
Farlow, MR
Citation: Dk. Lahiri et al., Studies with the memory-enhancing drug AIT-082 in PC12 cells, ALZHEIMER'S DISEASE, 2001, pp. 759-767
Authors:
Farlow, MR
Cyrus, PA
Citation: Mr. Farlow et Pa. Cyrus, Metrifonate therapy in Alzheimer's disease: A pooled analysis of four randomized, double-blind, placebo-controlled trials, DEMENT G C, 11(4), 2000, pp. 202-211
Authors:
Du, Y
Dodel, RC
Eastwood, BJ
Bales, KR
Gao, F
Lohmuller, F
Muller, U
Kurz, A
Zimmer, R
Evans, RM
Hake, A
Gasser, T
Oertel, WH
Griffin, WST
Paul, SM
Farlow, MR
Citation: Y. Du et al., Association of an interleukin 1 alpha polymorphism with Alzheimer's disease, NEUROLOGY, 55(4), 2000, pp. 480-483
Authors:
Aisen, PS
Davis, KL
Berg, JD
Schafer, K
Campbell, K
Thomas, RG
Weiner, MF
Farlow, MR
Sano, M
Grundman, M
Thal, LJ
Citation: Ps. Aisen et al., A randomized controlled trial of prednisone in Alzheimer's disease, NEUROLOGY, 54(3), 2000, pp. 588-593
Authors:
Henderson, VW
Paganini-Hill, A
Miller, BL
Elble, RJ
Reyes, PF
Shoupe, D
McCleary, CA
Klein, RA
Hake, AM
Farlow, MR
Citation: Vw. Henderson et al., Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial, NEUROLOGY, 54(2), 2000, pp. 295-301
Authors:
Dodel, RC
Du, Y
Bales, KR
Gao, F
Eastwood, B
Glazier, B
Zimmer, R
Cordell, B
Hake, A
Evans, R
Gallagher-Thompson, D
Thompson, LW
Tinklenberg, JR
Pfefferbaum, A
Sullivan, EV
Yesavage, J
Altstiel, L
Gasser, T
Farlow, MR
Murphy, GM
Paul, SM
Citation: Rc. Dodel et al., alpha 2 macroglobulin and the risk of Alzheimer's disease, NEUROLOGY, 54(2), 2000, pp. 438-442
Authors:
Evans, RM
Emsley, CL
Gao, S
Sahota, A
Hall, KS
Farlow, MR
Hendrie, H
Citation: Rm. Evans et al., Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans, NEUROLOGY, 54(1), 2000, pp. 240-242
Authors:
Takao, M
Benson, MD
Murrell, JR
Yazaki, M
Piccardo, P
Unverzagt, FW
Davis, RL
Holohan, PD
Lawrence, DA
Richardson, R
Farlow, MR
Ghetti, B
Citation: M. Takao et al., Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy, J NE EXP NE, 59(12), 2000, pp. 1070-1086
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
Authors:
Murrell, JR
Hake, AM
Quaid, KA
Farlow, MR
Ghetti, B
Citation: Jr. Murrell et al., Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene, ARCH NEUROL, 57(6), 2000, pp. 885-887
Authors:
Vidal, R
Calero, M
Piccardo, P
Farlow, MR
Unverzagt, FW
Mendez, E
Jimenez-Huete, A
Beavis, R
Gallo, G
Gomez-Tortosa, E
Ghiso, J
Hyman, BT
Frangione, B
Ghetti, B
Citation: R. Vidal et al., Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon 4 allele, ACT NEUROP, 100(1), 2000, pp. 1-12
Authors:
Lahiri, DK
Farlow, MR
Hintz, N
Utsuki, T
Greig, NH
Citation: Dk. Lahiri et al., Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease, ACT NEUR SC, 102, 2000, pp. 60-67
Authors:
Kawas, CH
Clark, CM
Farlow, MR
Knopman, DS
Marson, D
Morris, JC
Thal, LJ
Whitehouse, PJ
Citation: Ch. Kawas et al., Clinical trials in Alzheimer disease: Debate on the use of placebo controls, ALZ DIS A D, 13(3), 1999, pp. 124-129
Authors:
Brashear, A
Mulholland, GK
Zheng, QH
Farlow, MR
Siemers, ER
Hutchins, GD
Citation: A. Brashear et al., PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP), MOVEMENT D, 14(1), 1999, pp. 132-137
Authors:
Kramer, PL
Mineta, M
Klein, C
Schilling, K
de Leon, D
Farlow, MR
Breakefield, XO
Bressman, SB
Dobyns, WB
Ozelius, LJ
Brashear, A
Citation: Pl. Kramer et al., Rapid-onset dystonia-parkinsonism: Linkage to chromosome 19q13, ANN NEUROL, 46(2), 1999, pp. 176-182
Authors:
Farlow, MR
Cyrus, PA
Nadel, A
Lahiri, DK
Brashear, A
Gulanski, B
Citation: Mr. Farlow et al., Metrifonate treatment of AD - Influence of APOE genotype, NEUROLOGY, 53(9), 1999, pp. 2010-2016
Authors:
Rogers, SL
Friedhoff, LT
Farlow, MR
Doody, RS
Mohs, R
Citation: Sl. Rogers et al., Efficacy of donepezil in Alzheimer's disease: Fact or artifact? Reply, NEUROLOGY, 52(1), 1999, pp. 218-219